Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Healthtrust
Farmers Insurance
Covington
Julphar
Queensland Health
Baxter
Express Scripts

Generated: June 21, 2018

DrugPatentWatch Database Preview

Natco Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for NATCO PHARMA, and what generic and branded alternatives to NATCO PHARMA drugs are available?

NATCO PHARMA has nineteen approved drugs.

There is one tentative approval on NATCO PHARMA drugs.

Summary for Natco Pharma
US Patents:0
Tradenames:16
Ingredients:16
NDAs:19
Patent Litigation for Natco Pharma: See patent lawsuits for Natco Pharma

Drugs and US Patents for Natco Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 202595-002 Aug 3, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 202595-003 Aug 3, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd ANASTROZOLE anastrozole TABLET;ORAL 079220-001 Jun 28, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Natco Pharma Ltd ALPRAZOLAM alprazolam TABLET;ORAL 200739-004 Apr 15, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
Queensland Health
Express Scripts
Covington
Harvard Business School
Baxter
Argus Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.